Encapsulation ofN-Diazeniumdiolates within Liposomes for Enhanced Nitric Oxide Donor Stability and Delivery
- 28 August 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 12 (10) , 3569-3574
Abstract
The rapid decomposition of nitric oxide (NO) donors in aqueous environments remains a limitation for applications requiring extended NO release. Herein, we report the synthesis of dipalmitoylphosphatidylcholine-based liposomes capable of extended NO release using low molecular weight NO donors and a reverse-phase evaporation technique. The encapsulation of the NO donors within the liposomes enabled both prolonged NO release and enhanced storage compared to free NO donors alone. The NO-releasing liposomes also demonstrated enhanced efficacy against human pancreatic cancer cells. These NO-release vehicles represent attractive anticancer therapeutics due to their potential to store the majority of their NO payload until reaching cancerous tissue at which time the lower pH inherent to such environments will trigger an avalanche of NO.Keywords
Funding Information
- Division of Materials Research (DMR 1104892)
This publication has 33 references indexed in Scilit:
- Nitric Oxide-Releasing Dendrimers as Antibacterial AgentsBiomacromolecules, 2012
- Nitric oxide release: Part II. Therapeutic applicationsChemical Society Reviews, 2012
- The chemical biology of nitric oxide: Implications in cellular signalingFree Radical Biology and Medicine, 2008
- Control of apoptosis by p53Oncogene, 2003
- Nitric oxide-induced cellular stress and p53 activation in chronic inflammationProceedings of the National Academy of Sciences, 2002
- Chemistry of the Nitric Oxide-Releasing Diazeniumdiolate (“Nitrosohydroxylamine”) Functional Group and Its Oxygen-Substituted DerivativesChemical Reviews, 2002
- Nitric oxide and the immune responseNature Immunology, 2001
- Role of nitric oxide in the biology, physiology and pathophysiology of reproductionHuman Reproduction Update, 1998
- Nitric Oxide: Pathophysiological MechanismsAnnual Review of Physiology, 1995
- An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.Proceedings of the National Academy of Sciences, 1990